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Abstract:  14 
Mutations in MECP2 cause Rett syndrome (RTT), an X-linked neurological disorder 15 
characterized by regressive loss of neurodevelopmental milestones and acquired psychomotor 16 
deficits. However, the cellular heterogeneity of the brain impedes an understanding of how 17 
MECP2 mutations contribute to RTT. Here we developed a Cre-inducible method for cell type-18 
specific biotin tagging of MeCP2 in mice. Combining this approach with an allelic series of 19 
knockin mice carrying frequent RTT mutations (T158M and R106W) enabled the selective 20 
profiling of RTT-associated nuclear transcriptomes in excitatory and inhibitory cortical neurons. 21 
We found that most gene expression changes are largely specific to each RTT mutation and cell 22 
type. Lowly expressed cell type-enriched genes are preferentially disrupted by MeCP2 23 
mutations, with upregulated and downregulated genes reflecting distinct functional categories. 24 
Subcellular RNA analysis in MeCP2 mutant neurons further reveals reductions in the nascent 25 
transcription of long genes and uncovers widespread post-transcriptional compensation at the 26 
cellular level. Finally, we overcame X-linked cellular mosaicism in female RTT models and 27 
identified distinct gene expression changes between neighboring wild-type and mutant neurons, 28 










RTT is a progressive X-linked neurological disorder that represents one of the most common 38 
causes of intellectual disability among young girls. Patients experience a characteristic loss of 39 
acquired social and psychomotor skills and develop stereotyped hand movements, breathing 40 
irregularities, and seizures after 6-18 months of normal development
1
. Approximately 95% of 41 
RTT cases are mapped to the X-linked gene encoding methyl-CpG binding protein 2 (MeCP2), a 42 
ubiquitously expressed protein that is highly enriched in postmitotic neurons
2,3
. The majority of 43 
RTT-associated mutations cluster within two functionally distinct domains of MeCP2. The 44 
Methyl-CpG Binding Domain (MBD) allows MeCP2 to bind to methylated cytosines
4
. The 45 
Transcriptional Repression Domain (TRD) mediates protein-protein interactions with histone 46 
deacetylase-containing co-repressors, such as the NCoR-SMRT and mSin3A complexes
5–7
. 47 
These domains support MeCP2 as a chromatin factor that mediates transcriptional repression
7,8
, 48 
although transcriptional activation by MeCP2 is also reported
9–11
. 49 
Different mutations in MECP2, together with random X-chromosome inactivation (XCI), 50 
underlie a spectrum of clinical severity in RTT patients
12
. Among the most frequent RTT 51 
mutations, three are missense mutations in the MeCP2 MBD, including R106W (2.76% of RTT 52 
patients), R133C (4.24%), and T158M (8.79%)
13
. Typical RTT patients bearing the R133C 53 
mutation display milder clinical symptoms, whereas patients carrying the T158M or R106W 54 
mutation exhibit moderate or severe symptoms, respectively
12
. Although the clinical severity of 55 
these mutations scales with their effects on MeCP2 binding affinity to methylated DNA
14–17
, this 56 
relationship is not fully understood on a molecular level. Mouse models carrying RTT mutations 57 
can recapitulate this phenotypic variability, but most studies are limited to hemizygous male 58 
mice
17–21
. Despite that RTT predominantly affects heterozygous females, an experimental 59 
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strategy to selectively identify gene expression changes from Mecp2 mutant-expressing cells in a 60 
mosaic female brain has not yet been developed. 61 
Given that MeCP2 is a chromatin-bound nuclear protein, the identification of MeCP2 62 
transcriptional targets in the brain remains key towards illuminating RTT etiology
22
. However, 63 
target identification is confounded by the cellular heterogeneity of the brain, which contains 64 
multiple intermixed cell types that differ in morphology, function, electrophysiological 65 
properties, and transcriptional programs
23–25
. Analyses using heterogeneous brain tissues obscure 66 
cell type-specific gene expression changes, impeding the assessment of MeCP2 function at the 67 
transcriptional level
26
. The identification of transcriptional targets is further complicated by the 68 
widespread binding patterns of MeCP2 to methylated cytosines (mCpG and mCpA)
8,27,28
 or 69 
unmethylated GC-rich regions
29
 throughout the genome.  70 
In this study, we addressed the confounding effects of cellular heterogeneity by 71 
engineering genetically modified mice whereby MeCP2 is labeled with biotin using Cre-Lox 72 
recombination. To understand the molecular impact of RTT mutations on cell type-specific gene 73 
expression in vivo, we also developed an allelic series of knockin mice bearing one of two 74 
frequent RTT missense mutations, T158M and R106W. When combined with Fluorescence-75 
Activated Cell Sorting (FACS), this strategy allows for the isolation of neuronal nuclei from 76 
targeted cell types, effectively circumventing cellular heterogeneity in the mouse brain and X-77 
linked mosaicism in female mice. Our findings support a contextualized model by which cell 78 
autonomous and non-autonomous transcriptional changes in different cell types contribute to the 79 






Engineering a System to Genetically Biotinylate MeCP2 In Vivo: Biotin-mediated affinity 85 
tagging has been widely utilized in cell and animal models for multiple experimental approaches 86 
because of the strong (Kd = 4x10
-14
M) and specific interaction between biotin and avidin 87 
protein
30
. We exploited this approach to investigate MeCP2 function by using homologous 88 
recombination to insert a short 23-amino acid affinity tag immediately upstream of the Mecp2 89 
stop codon (Fig. 1a and Supplementary Fig. 1a). This tag comprises a TEV protease cleavage site 90 
and a 15-amino acid biotinylation consensus motif (termed Tavi, TEV and Avidin-binding) that 91 
can be post-translationally labeled with biotin by the E. coli biotin ligase, BirA. To biotinylate 92 
the tag in cell types of interest, we also generated Cre-dependent BirA transgenic mice (herein 93 
R26
cBirA
; Supplementary Fig. 1b). Therefore, upon crossing these mice to a cell type-specific Cre 94 
line, BirA is expressed and subsequently biotinylates MeCP2-Tavi (Fig. 1b). We used EIIa-Cre
31
 95 
to ubiquitously express BirA (R26
BirA
) and confirmed that MeCP2 is specifically biotinylated in 96 
vivo only when BirA is expressed and the Tavi tag is present (Fig. 1c and Supplementary Fig. 97 
1c). 98 
 To examine the possibility that tagging MeCP2 adversely affects its function, we 99 
assessed MeCP2 expression levels, DNA binding, and protein-protein interactions in 20-week 100 
old Mecp2
Tavi/y
 (herein TAVI) and littermate Mecp2
+/y
 (WT) mice. We found that total MeCP2 101 
protein, but not RNA, is significantly reduced by ~40% in TAVI mice, and a similar trend 102 
towards ~40% reduction is also observed among soluble and chromatin-bound protein fractions 103 
(Supplementary Fig. 1d-f). However, Tavi-tagged and untagged MeCP2 both exhibit comparable 104 
levels of chromatin binding at high and low affinity genomic sites, including highly methylated 105 
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major satellite repeats and IAP elements, and MeCP2-Tavi remains associated with the NCoR-106 
SMRT co-repressor (Supplementary Fig. 1g-h). Although a 50% reduction in MeCP2 expression 107 
is sufficient to cause hypoactivity and subtle behavioral phenotypes in mice
32
, TAVI mice appear 108 
similar to WT mice and do not display overt RTT-like features using phenotypic scoring
33
 over 109 
an observational period of 20 weeks (Fig. 1g-j, Supplementary Fig. 1i, and data not 110 
shown/B.S.J).  111 
 112 
MeCP2 Missense Mutations Recapitulate RTT-like Phenotypes in Mice: To examine the 113 
molecular relationship between MeCP2 affinity for methylated DNA and phenotypic severity, 114 
we generated independent Mecp2
T158M-Tavi
 (herein T158M) and Mecp2
R106W-Tavi
 (R106W) knock-115 
in mice in parallel with TAVI mice (Fig. 1a). Relative to TAVI controls, we found that T158M 116 
and R106W mice both display a ~70-80% reduction in MeCP2 protein expression despite 117 
equivalent levels of mRNA at 6 weeks of age (Fig. 1e, Supplementary Fig. 1j), similar to other 118 
mouse models bearing MeCP2 MBD mutations
17,18,21
. However, there is a trend towards 119 
relatively higher MeCP2 protein levels in T158M than R106W mice across development 120 
(Supplementary Fig. 2a). Immunofluorescent (IF) staining of hippocampal sections from T158M 121 
and R106W mice revealed diffusely distributed MeCP2 throughout the nucleus that accompanied 122 
a loss of localization to heterochromatic foci, supporting the impaired binding of mutant MeCP2 123 
to mCpGs in vivo (Fig. 1d). Streptavidin IF, which is noticeably lower in Mecp2 mutant mice, 124 
also confirmed a loss of mutant MeCP2 localization to heterochromatic foci and further 125 
illustrated a redistribution of mutant MeCP2 to the nucleolus (Fig. 1d and Supplementary Fig. 126 
2b-c), a property reminiscent of GFP-tagged MeCP2 lacking its MBD
34
.  127 
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 Using sub-nuclear fractionation, we confirmed that a greater proportion of MeCP2 128 
T158M or R106W protein occupies the soluble fraction when compared to WT or TAVI protein 129 
(Supplementary Fig. 2d), consistent with the loss of chromatin binding in mutant mice (Fig. 1d). 130 
By further extracting chromatin-bound MeCP2 with different salt concentrations, we found that 131 
MeCP2 R106W is more readily released at lower salt concentrations (200mM NaCl) than 132 
MeCP2 WT, TAVI, or T158M protein, suggesting that MeCP2 R106W has the lowest binding 133 
affinity for chromatin (Fig. 1f and Supplementary Fig. 2e). Phenotypic comparisons revealed that 134 
T158M and R106W mice both exhibit RTT-like features similar to that of Mecp2-null mice, 135 
including decreased brain and body weight, and an age-dependent increase in phenotypic score 136 
(Fig. 1g-i). Although lifespan is significantly reduced in all three Mecp2 mutant mice, the 137 
median survival of R106W mice more closely resembles that of Mecp2-null than T158M mice 138 
(Fig. 1j). Both mutations demonstrated a significant difference in survival curves (T158M 139 
median survival = 14 weeks; R106W median survival = 10 weeks; Mantel Cox P = 0.012). 140 
Together, these data suggest that T158M and R106W mutations represent a partial and complete 141 
loss-of-function, respectively. 142 
 143 
Genetic Biotinylation Permits Cell Type-specific Transcriptional Profiling: We next devised 144 
a biotinylation-based strategy for cell type-specific nuclei isolation and transcriptional profiling 145 
(Fig. 2a-b). We used the NeuroD6/NEX-Cre line
35
 to drive BirA expression and MeCP2-Tavi 146 
biotinylation in forebrain excitatory neurons (Fig. 2a and Supplementary Fig. 3a-g). 147 
Quantification of pan-neuronal (NeuN), pan-inhibitory (GAD67), and inhibitory-specific 148 







 (herein NEX-Cre) mice demonstrated that biotinylation occurs in 150 
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~80% of NeuN+ cortical neurons devoid of inhibitory markers (Supplementary Fig. 3h). FACS 151 
using stained cortical nuclei from NEX-Cre mice identified three distinct nuclear populations 152 
(Fig. 2c). RT-PCR for cell type-specific markers confirmed that NeuN+Biotin+ nuclei reflect 153 
excitatory neurons, whereas NeuN+Biotin- nuclei represent a mixture of inhibitory interneuron 154 
subtypes (Fig. 2c-d). Astrocytic, microglial and oligodendrocytic markers are restricted to the 155 
third, non-neuronal population of NeuN-Biotin- nuclei (Fig. 2c-d). We also used the Dlx5/6-Cre 156 
line
36
 to drive BirA expression in forebrain GABAergic neurons and obtained results inverse to 157 
that of NEX-Cre (Fig. 2a and Supplementary Fig. 3a-j), confirming that MeCP2-Tavi is reliably 158 
biotinylated in Cre-defined cell types. 159 
Because MeCP2 is known to modulate transcription
22
, nuclear RNA-seq would afford an 160 
unique opportunity to study the primary effects of RTT mutations on gene expression. We thus 161 
performed transcriptional profiling in 6-week old male mice near the onset of RTT-like 162 
phenotypes. We employed the NEX-Cre driver and isolated cortical excitatory and inhibitory 163 
nuclei from T158M, R106W and TAVI mice via FACS, followed by total RNA-seq 164 
(Supplementary Table 1). Biological replicates were well-correlated (Fig. 2e), and ~74% of total 165 
reads mapped to introns, serving as a proxy for chromatin-associated transcriptional activity
37,38
.  166 
Unsupervised hierarchical clustering shows that replicate transcriptomes from cortical excitatory 167 
and inhibitory neurons in TAVI mice are highly correlated by cell type, and genic-mapped reads 168 
illustrate selectively expressed genes in each cell type (Fig. 2e-f and Supplementary Fig. 4a). We 169 
identified 9,379 differentially expressed genes (DEGs, FDR < 0.05) between excitatory and 170 
inhibitory neurons, the majority (86.9%) of which comprise protein-coding genes (Table 1 and 171 
Supplementary Fig. 4b). Among the protein-coding fraction of cell type-enriched DEGs, 3,958 172 
genes (0.15 – 4.70 fold change) display Gene Ontology (GO) functions consistent with 173 
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glutamatergic pyramidal cell types (EXC-enriched; Supplementary Fig. 4c), whereas the 174 
remaining 4,194 genes (0.17 – 7.77 fold change) exhibit GO functions consistent with 175 
metabolically active GABAergic interneurons (INH-enriched; Supplementary Fig. 4d). 176 
  177 
Protein-Coding Genes are More Severely Affected in R106W Mice: We next compared 178 
nuclear gene expression profiles in excitatory and inhibitory neurons between mutant (T158M, 179 
R106W) and control (TAVI) mice to identify and characterize DEGs associated with the 180 
appearance of RTT-like phenotypes (Fig. 3a). We identified more DEGs in excitatory and 181 
inhibitory neurons of R106W than T158M mice, indicating that the number of misregulated 182 
genes positively scales with the severity of the Mecp2 mutation (Fig. 3b and Table 1). More than 183 
90% of MeCP2 DEGs are protein-coding genes (Supplementary Fig. 5a), significantly higher 184 
than the percentage of protein-coding genes in the genome (60.4%), or among actively expressed 185 
(77.7-78.3%) and cell type-enriched (86.2-87.7%) genes (Supplementary Fig. 4b). We therefore 186 
excluded non-coding genes from further analyses. We note that the number and percentage of 187 
protein-coding DEGs overlapping between T158M and R106W genotypes is greater in inhibitory 188 
(107 genes) than excitatory neurons (69 genes). Moreover, overlapping DEGs tend to be 189 
misregulated in the same direction (Fig. 3c).  190 
The median fold change of T158M and R106W DEGs is small in mutant neurons 191 
compared to overall differences in gene expression between excitatory and inhibitory neurons 192 
(Supplementary Fig. 5b and Table 1). We further compared fold changes between T158M and 193 
R106W DEGs, limiting our analysis to protein-coding genes that overlap between genotypes to 194 
account for disproportionate numbers of DEGs. Within this subset, we found that the median 195 
fold change among upregulated and downregulated DEGs is consistently higher in both cell 196 
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types of R106W mice than those of T158M mice (Fig. 3c), consistent with a more severe 197 
phenotype in R106W mice.   198 
 199 
Transcriptional Features of T158M and R106W DEGs: We next compared MeCP2 DEGs 200 
across excitatory and inhibitory neurons and found limited overlap between the two cell types 201 
(6.2% of T158M DEGs, 10.7% of R106W DEGs; Fig. 3d), indicating that most DEGs reflect cell 202 
type-specific transcriptional changes. Indeed, EXC/INH-enriched genes are significantly 203 
overrepresented among MeCP2 DEGs in each cell type, comprising ~70-80% of genes (Fig. 3e 204 
and Table 1). Moreover, EXC- and INH-enriched genes are preferentially downregulated and 205 
upregulated, respectively, in each cell type (Fig. 3e and Supplementary Fig. 5c). 206 
 We next performed a pre-ranked Gene Set Enrichment Analysis (GSEA, FDR < 0.1) to 207 
determine whether upregulated and downregulated DEGs represent functionally distinct 208 
categories. Upregulated DEGs in T158M and R106W mice are both primarily associated with 209 
transcriptional regulation. These include DNA-binding transcriptional activators, repressors, and 210 
chromatin remodelers, most of which tend to be INH-enriched genes (Fig. 3f and Supplementary 211 
Fig. 5d). Significant functional categories associated with downregulated DEGs, however, are 212 
specifically detected in R106W excitatory neurons and enriched for post-synaptic membrane 213 
proteins, including various ion channels, synaptic scaffolding proteins, and ionotropic glutamate 214 
receptors (Fig. 3f). Although significant gene functions were not identified among 215 
downregulated DEGs in inhibitory neurons using our GSEA FDR cutoff, gene functions 216 
associated with upregulated DEGs in R106W inhibitory neurons are related to cellular 217 
metabolism and signal transducer activity (Supplementary Fig. 5e).  218 
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Upon examining the relative expression levels of MeCP2 DEGs using Fragments Per 219 
Kilobase of transcript per Million mapped reads (FPKM), we noticed that T158M, R106W, and 220 
overlapping DEGs display significantly lower FPKM values relative to total expressed genes in 221 
each cell type (Fig. 3g). To exclude the possibility of gene filtering biases associated with RNA-222 
seq, we randomly selected 12 low-expressing DEGs that overlap between both mutations and 223 
independently measured their primary and mature RNA transcripts in excitatory neuronal nuclei 224 
using RT-PCR (Supplementary Table 2). We found that 10 out of 12 genes show significant gene 225 
expression changes that resemble those using RNA-seq (83.3% positive validation rate; 226 
Supplementary Fig. 6a-b), confirming that genes with low transcriptional activity are indeed 227 
affected by MeCP2 mutations. To examine whether lowly expressed genes are selectively 228 
enriched for MeCP2 DEGs, we binned actively expressed genes from each cell type into four 229 
percentiles (Q1-Q4) according to expression level. EXC- and INH-enriched genes served as 230 
reference distributions across percentiles for each cell type (Supplementary Fig. 6c). In 231 
comparison, T158M and R106W DEGs are preferentially enriched in Q1, the bottom 25
th
 232 
percentile of actively expressed genes, in both excitatory and inhibitory neurons (Fisher Exact 233 
one-tailed P, T158M: EXC = 1.11e-07, INH = 2.03e-04; R106W: EXC = 4.04e-08, INH = 1.50e-234 
02; Supplementary Fig. 6c). Between the two mutations, T158M DEGs are more likely to be 235 
lowly expressed than R106W DEGs (Fisher Exact Odds Ratio (OR) for Q1, T158M: EXC = 3.1, 236 
INH = 3.2; R106W: EXC = 2.0, INH = 1.3; Supplementary Fig. 6c). Accordingly, R106W-237 
specific DEGs have significantly higher FPKM values than T158M DEGs in both cell types and 238 
are predominantly downregulated in R106W neurons (Fig. 3g and Supplementary Fig. 6d). This 239 
preferential downregulation of high-expressing genes appears consistent with the specific loss of 240 
synaptic gene functions in R106W excitatory neurons (Fig. 3f-g and Supplementary Fig. 6d). 241 
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 242 
Subcellular RNA Pools Reveal Global Transcriptional and Post-transcriptional Changes: 243 
Two recent reports implicate MeCP2 in the transcriptional repression of long genes, which are 244 
preferentially upregulated in the neurons of multiple RTT models
27,39
. We therefore examined 245 
the possibility that genome-wide transcriptional changes may correlate with T158M and R106W 246 
phenotypic and molecular severity. Similar to those studies, we sorted and binned expressed 247 
protein-coding genes according to gene length and measured the mean fold change in Mecp2 248 
mutant neurons. Notably, nuclear transcriptomes revealed a striking inversion of previously 249 
reported gene expression changes whereby short (≤ 100kb in gene length) and long (> 100kb in 250 
gene length) genes trend towards upregulation and downregulation, respectively, in a length-251 
dependent manner (Supplementary Fig. 7a). 252 
 Although most nuclear RNAs comprise intron-containing pre-mRNA transcripts on 253 
chromatin, the presence of processed mRNA transcripts awaiting nuclear export may potentially 254 
confound the assessment of transcriptional events
40
. We therefore performed global nuclear run-255 
on with high-throughput sequencing (GRO-seq
41
) to directly assess de novo transcriptional 256 
activity by RNA polymerase in cortical nuclei of TAVI and R106W mice. Similar to sorted 257 
nuclear RNA, the nascent transcription of short and long genes in R106W neurons is 258 
predominantly increased and decreased, respectively (Fig. 4a). LOESS local regression of DEGs 259 
that were identified in R106W excitatory and inhibitory neurons also revealed a similar overall 260 
trend towards the preferential downregulation of long genes (Fig. 4a). The genome-wide trend 261 
we observe in sorted nuclear RNA thus represents a primary effect at the transcriptional level, 262 
prompting us to further investigate if the length-dependent upregulation of long genes that was 263 
previously reported may represent an indirect effect of MeCP2-dependent transcriptional 264 
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deregulation. To test this, we resected cortical tissue from TAVI and R106W mice, and subjected 265 
each cortical half to whole cell or nuclear RNA isolation in parallel, followed by sequencing. 266 
Cortical whole cell RNA from mutant mice displayed a length-dependent increase in the mean 267 
expression of long genes (Fig. 4b), similar to what was previously described
27,39
. In contrast, 268 
cortical nuclear RNA isolated from the same TAVI and R106W mice exhibited a length-269 
dependent upregulation of short genes and downregulation of long genes (Fig. 4c), corroborating 270 
the transcriptional changes we observed from nascent RNA (Fig. 4a) and nuclear RNA from 271 
sorted nuclei (Supplementary Fig. 7a). Using the 10,390 expressed genes associated with de novo 272 
transcription by GRO-seq (Fig. 4d), we observed that genes upregulated in nascent and nuclear 273 
RNA pools are cumulatively shorter in length relative to those upregulated in whole cell RNA, 274 
and the inverse was observed among downregulated genes (Fig. 4e). Thus, gene expression 275 
changes in Mecp2 mutant neurons appear to be substantially different between subcellular 276 
compartments. 277 
 To directly compare individual genes across subcellular compartments, we next classified 278 
all 10,390 expressed genes into eight subgroups that reflect the total number of arrangements by 279 
which a gene can be misregulated across three given RNA pools (2
3
 = 8). Groups B and D 280 
comprise 38.4% of expressed genes which are involved in neuronal projection and cellular stress, 281 
respectively, and represent expression changes that are misregulated in the same direction across 282 
nascent, nuclear, and whole cell RNA pools (Fig. 4f and Supplementary Fig. 7b). Among these 283 
groups of genes, log2 fold changes measured from the whole cell are significantly smaller than 284 
that in the nuclear compartment, suggesting that gene expression changes in the nucleus are post-285 
transcriptionally minimized in the cell (Fig. 4f and Supplementary Fig. 7c). The majority of 286 
genes (48%), however, exhibit expression changes in nascent RNAs that are reversed in the 287 
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whole cell compartment (Groups A,C,G,H; Fig. 4f). Groups A and C consist of relatively long, 288 
EXC-enriched genes that are transcriptionally downregulated in nascent RNA but post-289 
transcriptionally upregulated in whole cell RNA (Fig. 4f and Supplementary Fig. 7d-e). DAVID 290 
gene ontology revealed that Group A genes are associated with synaptic functions and 291 
intracellular signaling (Fig. 4g). Groups G and H consist of considerably shorter, INH-enriched 292 
genes that are transcriptionally upregulated in nascent RNA but post-transcriptionally 293 
downregulated in whole cell RNA (Fig. 4f and Supplementary Fig. 7d-e), and Group G genes are 294 
functionally associated with cellular energy and metabolism in mitochondria (Fig. 4g). RT-PCR 295 
validation of primary and mature RNA transcripts for several genes from Groups A/C, B, and D 296 
recapitulated these apparent expression differences between subcellular compartments, 297 
particularly when genes were analyzed as a collective in their respective Group (Fig. 4h, 298 
Supplementary Fig. 8 and Supplementary Table 2). Notably, upon analyzing de novo 299 
transcriptional activity derived from GRO-seq for genes expressed in sorted excitatory or 300 
inhibitory neurons (Supplementary Fig. 7f), we found a trend towards long genes being more 301 
severely downregulated in both cell types bearing the R106W mutation than the T158M 302 
mutation (Fig. 4i and Supplementary Fig. 7g), consistent with a more severe phenotype in 303 
R106W mice. 304 
 To gain insight into the apparent switch in gene misregulation between subcellular 305 
compartments, we next used publically available HITS-CLIP datasets from the mouse brain to 306 
examine genes whose transcripts are typically bound and regulated by RNA-binding proteins 307 
(RBPs), and tested for associations with distinct subcellular gene expression changes in Mecp2 308 
mutant neurons. K-means clustering of 10,390 cortically expressed genes across HITS-CLIP data 309 
for 12 RBPs (MBNL1-2, TDP43, FUS, TAF15, FMR1, HuR, APC, RBFOX1-3, and AGO2) 310 
 15
identified 5 major gene clusters (Supplementary Fig. 9a). We found one subset of genes whose 311 
transcripts display significantly higher levels of HuR binding, but lower levels of AGO2 binding 312 
(RBP Clusters 1 and 4), and another subset showing significantly higher levels of AGO2 binding 313 
but lower levels of HuR binding (RBP Clusters 2, 3 and 5; Supplementary Fig. 9b-c). HuR binds 314 
to the 3’UTR of mRNA transcripts (Supplementary Fig. 9d) and is known to increase mRNA 315 
stability
42
. Conversely, AGO2 functions to promote mRNA degradation through AGO2-bound 316 
miRNAs
43
. Both HuR and AGO2 genes are also actively expressed in neurons at 6-weeks of age 317 
(Supplementary Fig. 9e). By comparing gene Groups A-H, which summarize subcellular gene 318 
expression changes in Mecp2 mutant neurons (Fig. 4f), to functionally-distinct RBP clusters 319 
(Supplementary Fig. 9a-c), we found that many downregulated nascent RNA transcripts from 320 
Groups A, B, and C are significantly associated with RBP Clusters 1 and 4 and are post-321 
transcriptional targets of HuR (Supplementary Fig. 9f). By contrast, upregulated nascent RNA 322 
transcripts in Mecp2 mutant neurons, particularly from Groups G and H, show associations with 323 
RBP Clusters 2, 3, and 5, and are targets of AGO2-bound miRNAs (Supplementary Fig. 9f). The 324 
opposite functions of HuR and AGO2 in the post-transcriptional regulation of mRNA stability 325 
likely alter the abundance of cellular RNAs in a group- or cluster-specific manner. Therefore, 326 
gene expression differences between subcellular compartments in Mecp2 mutant mice could be 327 
post-transcriptionally mediated in part by RBPs (Supplementary Fig. 9g).  328 
 329 
Female RTT Mouse Models Reveal Cell and Non-Cell Autonomous DEGs: RTT is an X-330 
linked disorder that primarily affects heterozygous females. However, the extent to which 331 
intermixed Mecp2 WT and mutant (MUT) neurons in cellular mosaic RTT females affect each 332 
other at the level of gene expression remains unknown. The reduced expression level of T158M 333 
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and R106W mutant protein allowed us to use the same tagging and sorting strategy in male mice 334 
to isolate and profile WT (denoted by subscript: T158MWT, R106WWT) and MUT (T158MMUT, 335 




















) heterozygous females that each carry a Tavi-tagged WT 338 
allele and a Tavi-tagged T158M, R106W, or untagged WT allele. Upon aging these mice to ~18 339 
weeks, when T158M and R106W females both exhibit RTT-like phenotypes (Fig. 5a), cortical 340 
excitatory nuclei were isolated for FACS (Fig. 5b-c and Supplementary Fig. 10a). From the 341 
number of females sampled, we did not detect skewed XCI (> 75%) among excitatory neurons in 342 
TAVI, T158M, or R106W mice (Fig. 5d). 343 
 By comparing the gene expression profiles of WT or MUT neurons from heterozygous 344 
mutant mice to those from control mice (TAVIWT), a total of 526 and 678 unique protein-coding 345 
DEGs in T158MWT and MUT and R106WWT and MUT neurons were identified, respectively (Fig. 5e, 346 
Supplementary Fig. 10b and Table 1). Most DEGs represent cell autonomous gene expression 347 
changes that occur in mutant neurons alone (Fig. 5e). However, a larger proportion of R106W 348 
DEGs are also found in R106WWT neurons (43.4%; Fig. 5e), revealing a mutation-specific 349 
susceptibility of WT neurons to non-cell autonomous gene expression changes in heterozygous 350 
females. Using principal component analysis (PCA) to plot the first two major axes of 351 
transcriptome variation, we found that PC2 separates neuronal populations by Mecp2 allele 352 
status (WT vs. MUT neurons) irrespective of the T158M or R106W mutation (Fig. 5f), 353 
indicating that Mecp2 mutations induce cell autonomous changes that are transcriptionally 354 
distinct from neighboring wild-type neurons. However, PC1 accounts for nearly twice the 355 
variation as PC2 and clusters R106WWT and MUT populations away from other genotypes, likely 356 
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due to the extensive number of indirect DEGs associated with this mutation. In contrast, against 357 
PC1 and PC2, T158MWT neurons closely resemble TAVIWT (Fig. 5f), indicating that the non-cell 358 
autonomous DEGs observed in R106WWT neurons specifically arise due to the increased severity 359 
of R106W mutation in R106WMUT neurons. 360 
We further found 194 DEGs that overlap between T158M and R106W female mice, most 361 
of which are misregulated in the same direction (Fig. 5g). Among these genes, cell autonomous 362 
transcriptional changes (149 genes, 76.8%) are more likely to be shared across independent 363 
Mecp2 mutations than non-cell autonomous changes (9 genes, 4.6%; Fig. 5h). These overlapping 364 
DEGs also show higher fold changes in R106W than T158M female mice, but this difference is 365 
mainly driven by indirect DEGs in R106W neurons (Fig. 5i). 366 
In R106W female mice, we found that non-cell autonomous DEGs are predominantly 367 
upregulated (~60%) in contrast to cell autonomous DEGs (~48%; Supplementary Fig. 10b), and 368 
display significantly higher fold changes than cell autonomous DEGs (Supplementary Fig. 10c). 369 
Furthermore, cell autonomous DEGs are considerably longer in gene length, specifically among 370 
upregulated genes (Supplementary Fig. 10d). To determine if cell and non-cell autonomous 371 
DEGs represent distinct biological processes, we also performed pre-ranked GSEA (FDR < 0.1) 372 
and found that non-cell autonomous gene expression changes primarily affect cell-to-cell 373 
signaling and negative regulation of protein phosphorylation (Supplementary Fig. 10e). These 374 
DEGs include several immediate early and late response genes that are induced by neuronal 375 
activity and modulate signaling pathways associated with synaptic plasticity
44
. In contrast, cell 376 
autonomous DEGs are significantly associated with transcriptional regulation (Supplementary 377 
Fig. 10f). These functional categories demonstrate a marked resemblance to those observed in 378 
excitatory neurons of male T158M and R106W mice (Fig. 5j). The striking consistency with 379 
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which these functional annotations characterize Mecp2 mutant neurons, despite apparent 380 
differences in age and sex, supports the cell autonomous disruption of these functions as a key, 381 
contributing factor to RTT pathogenesis. 382 
 383 
Discussion: The complexity of MeCP2 molecular function, coupled with the cellular 384 
heterogeneity of the brain, confounds the study of transcriptional changes in RTT. We thus 385 
combined in vivo biotinylation with Cre-Lox technology to label both wild-type and mutant 386 
MeCP2 from different neuronal populations and examined RTT-associated transcriptomes in 387 
mice. Notably, the 23AA Tavi tag can be readily used to target any given protein using CRISPR-388 
Cas9 technology
45
 for cell type-specific biochemical purifications, molecular profiling, and 389 
imaging applications.  390 
By using an allelic series of RTT mutations to perform a transcriptome analysis of 391 
cortical neurons, we identified similarities and differences in gene expression features that 392 
couple impairments in MeCP2’s ability to bind DNA to RTT phenotypic severity. We found that 393 
lowly-expressed, cell type-enriched genes are sensitive to the effects of both T158M and R106W 394 
mutations, which likely contributes to the specificity of MeCP2-mediated gene expression 395 
changes among different neuronal cell types. Both mutations also display conserved 396 
transcriptional features among upregulated DEGs in male and female neurons, which include 397 
genes encoding INH-enriched transcription factors and chromatin remodelers. The upregulation 398 
of transcriptional regulators could contribute to the shared RTT etiology between T158M and 399 
R106W mice, as well as the genome-wide trend towards increased transcription of shorter, INH-400 
enriched genes associated with cellular respiration and energy metabolism. This provides 401 
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transcriptional insight into clinical features among both mildly and severely affected RTT 402 
patients that resemble mitochondrial and metabolic disorders
46
. 403 
However, the greater impairment in MeCP2 R106W binding to neuronal chromatin 404 
associates with increased RTT phenotypic severity, and notably correlates with the larger 405 
number and degree of misregulated genes that are more highly expressed and predominately 406 
downregulated relative to the T158M mutation. These transcriptional differences extend to most 407 
long genes throughout the genome, which are highly expressed in neurons
47
. Our datasets are in 408 
partial agreement with global reductions in Ser5-phosphorylated RNA polymerase in Mecp2-null 409 
neuronal nuclei
48
, supporting MeCP2 as a global modulator of gene transcription. Loss of 410 
MeCP2 occupancy may either alter local chromatin organization, which could decrease the 411 
efficiency of transcriptional elongation
49
 and lead to the downregulation of long genes, or may 412 
abrogate HDAC3-mediated recruitment of transcription factors required for long gene 413 
transcriptional activation
50
. Because downregulated genes associate with synaptic morphology 414 
and function, and R106W mice have reduced lifespans compared to T158M mice, reductions in 415 
long gene transcription may act as modifiers to worsen RTT-like phenotypes. RTT patients with 416 
mutations that preserve MeCP2 binding do exhibit milder features than patients for whom 417 
binding is disrupted
12
. Transcriptional assessments with mutations preserving MeCP2 binding 418 
are thus necessary to further refine these genotype-phenotype correlations. 419 
Because MeCP2 is a DNA-binding nuclear protein
22
, nuclear and nascent RNA pools 420 
provide additional insights into the primary effects of RTT mutations on transcriptional 421 
activity
37,38,51
 that complement the reported whole cell upregulation of long genes in RTT
27,39
. 422 
Whole cell RNA is subject to post-transcriptional regulation
40,52,53
, being notably enriched for 423 
cytoplasmic mRNAs that are bound by various RBPs to modulate their steady-state abundance 424 
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and turnover. We found that many downregulated nascent RNA transcripts are targets of HuR, 425 
which increases mRNA stability in the brain
42
 and may post-transcriptionally upregulate these 426 
transcripts in whole cell RNA. Upregulated nascent RNA transcripts tend to associate with 427 
miRNA-bound AGO2, which may post-transcriptionally mitigate their upregulation by 428 
increasing rates of mRNA decay
43
. These post-transcriptional mechanisms may abate cellular 429 
consequences arising from global alterations in synaptic, mitochondrial, and metabolic gene 430 
transcription. Whole cell gene expression changes in RTT may thus be compensatory and not 431 
entirely representative of transcriptional activity, questioning the therapeutic benefit of 432 
decreasing long gene transcription for treating RTT.  Identifying RBPs that contribute to cellular 433 
compensation may yield a novel class of interventional therapies administered prior to or during 434 
the initial phases of RTT, minimizing its pathological impact. 435 
Finally, our approach allows for the molecular profiling of mosaic neurons from female 436 
mice that represent accurate preclinical RTT models, revealing non-cell autonomous changes in 437 
WT neurons that depend on mutation severity. However, to better elucidate direct and indirect 438 
contributions to RTT, further investigation requires examination of females with a wide range of 439 
XCI ratios across multiple ages, cell types, and Mecp2 mutations. Non-cell autonomous DEGs 440 
include genes induced by neuronal activity to reduce synaptic responsiveness to excessive 441 
neuronal stimuli
44
. Nuclear RNA transcripts of two late-response genes in particular, Bdnf and 442 
Igf1, were found to be transcriptionally upregulated in WT and MUT neuronal nuclei of 18-week 443 
old R106W female mice. As Bdnf and Igf1 encode neuroprotective peptides that ameliorate RTT 444 
symptoms
20
, the selective upregulation of non-cell autonomous DEGs in R106W mice may be a 445 
protective response to increased neuronal activity or stress among severely affected mosaic 446 
neurons. Currently, BDNF and IGF-1 peptides are being tested in clinical trials
54,55
. Further study 447 
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of molecular pathways associated with non-cell autonomous DEGs may thus reveal additional 448 
RTT therapeutic targets and avenues. 449 
 450 
Data availability: All sequencing data reported in this study has been deposited in the NCBI 451 
Gene Expression Omnibus (GSE83474). Mouse lines generated from this study have been 452 
deposited at The Jackson Laboratory (Bar Harbor, ME) under the following stock numbers: 453 
R26
cBirA
 (Stock #030420), Mecp2
Tavi
  (Stock #030422), Mecp2
T158M-Tavi
 (Stock #029642), and 454 
Mecp2
R106W-Tavi
 (Stock #029643). 455 
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Figure 1. Utilization and characterization of Mecp2
Tavi
 mice and associated RTT variants. (a) 600 
Diagram of wild-type and tagged MeCP2 showing R106W or T158M missense mutations. MBD, 601 
Methyl-CpG Binding Domain; TRD, Transcriptional Repression Domain. (b) Breeding strategy 602 
to biotinylate the Tavi tag in a Cre-dependent manner. (c) Representative western blot showing 603 
the conditions in which the Tavi tag is biotinylated using whole brain nuclear extracts. Blot is 604 
probed with streptavidin for biotin detection and antibodies against MeCP2 N-terminus, Tavi tag, 605 
and NeuN. (d) Representative images showing immunofluorescent detection of biotinylated 606 
MeCP2 and mutant variants in hippocampal sections of untagged (WT) and tagged (TAVI, 607 
T158M, R106W) male mice at 6 weeks of age. Tissue is probed with streptavidin for biotin 608 
detection and antibody against the MeCP2 C-terminus. Scale bars represent 10 µm. (e) 609 
Quantification and representative western blot comparing MeCP2 protein expression levels 610 
between TAVI and mutant (T158M, R106W) male mice at 6 weeks of age. Blot is probed with 611 
antibodies against the MeCP2 C-terminus and TBP (nreplicates = 3, One-way ANOVA). (f) 612 
Quantification of salt-extracted MeCP2 from chromatin using 200mM (left) and 400mM (right) 613 
NaCl, normalized to extracts using 500mM NaCl (see Supplemental Fig. 2e; nreplicates = 4-5, One-614 
way ANOVA). (g) Box-and-whisker plot of brain weights from untagged (WT, KO (Mecp2-615 
null)) and tagged (TAVI, T158M, R106W) male mice at 6 weeks of age (nWT = 20, nTAVI = 11, 616 




 percentiles, 617 
center line denotes median, ‘+’ denotes mean, and whiskers denote data max and min. Each 618 
genotype is indicated with a different color. (h) Body weight over postnatal age in untagged 619 
(WT, KO) and tagged (TAVI, T158M, R106W) male mice. Data points consist of at least 6 620 
observations each. Total number of mice assessed: nWT = 31, nTAVI = 23, nKO = 15, nT158M = 14, 621 
nR106W = 28. (i) RTT-like phenotypic score across postnatal development in untagged (WT, KO) 622 
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and tagged (TAVI, T158M, R106W) male mice. Data points over time consist of at least 6 623 
observations each. Total number of mice assessed: nWT = 31, nTAVI = 23, nKO = 15, nT158M = 14, 624 
nR106W = 28. (j) Kaplan-Meier survival curve for untagged (WT, KO) and tagged (TAVI, 625 
T158M, R106W) male mice (nWT = 31, nTAVI = 23, nKO = 17, nT158M = 39, nR106W = 26). *P < 0.5, 626 
**P < 0.01, ***P < 0.001, ****P < 0.0001, n.s. = not significant; all pooled data depicts mean ± 627 
SEM unless otherwise stated. See also Supplementary Figs. 1 and 2. 628 
  629 
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 630 
Figure 2. Cell type-specific transcriptional profiling of neuronal nuclei. (a) Representative 631 
images showing immunofluorescent detection of biotinylated MeCP2-Tavi protein in Cre-632 
specified neuronal populations of the mouse hippocampus. Probed using streptavidin for biotin 633 
detection and antibody against the MeCP2 C-terminus. Scale bars represent 100µm. (b) 634 
Schematic of cortical nuclei preparation and FACS isolation. (c) FACS analysis of labeled 635 
cortical nuclei populations. Data shown is representative of nine independent experiments using 636 
NEX-Cre mice. Percentages indicate the mean distribution of neurons that are NeuN+Biotin+ 637 
(excitatory; 85.2% ± 0.35) or NeuN+Biotin- (inhibitory; 14.8% ± 0.35). (d) RT-PCR validation 638 
of FACS-isolated populations depicted in (c) (nreplicates = 3, Two-way ANOVA). (e) Pearson 639 
correlation of biological replicate nuclear RNA-seq libraries within (intra-replicate) and across 640 
(inter-replicate) FACS-isolated populations depicted in (c). Colors correspond to EXC-enriched 641 
(blue) and INH-enriched (red) genes identified through differential expression analysis of 642 
excitatory and inhibitory neurons. Note lower Pearson correlation and clear dispersal of cell 643 
type-enriched genes across FACS populations. (f) IGV browser snapshot of Dlgap1 genomic 644 
locus in excitatory and inhibitory neurons of TAVI male mice at 6 weeks of age. RefSeq and 645 
Ensembl gene annotations are both shown. *P < 0.5, **P < 0.01, ***P < 0.001, ****P < 0.0001, 646 
n.s. = not significant; all pooled data depicts mean ± SEM. See also Supplementary Figs. 3 and 647 
4. 648 
 649 
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Figure 3. Analysis of T158M and R106W differentially expressed genes. (a) FACS isolation of 651 
cortical excitatory and inhibitory neuronal nuclei from TAVI, T158M, or R106W male mice at 6 652 
weeks of age. (b) Total number of protein coding and non-coding differentially expressed genes 653 
(DEGs) identified in excitatory or inhibitory neurons of Mecp2 mutant mice. (c) Heatmaps 654 
display log2 fold changes among protein-coding DEGs in excitatory and inhibitory neurons of 655 
Mecp2 mutant mice, compared across genotypes. Excitatory DEGs nshared = 69 genes, 656 
Hypergeometric P = 3.15e
-77
. Inhibitory DEGs nshared = 107 genes, Hypergeometric P = 5.33e
-134
. 657 
Boxplots compare log2 median fold changes among overlapping DEGs between T158M and 658 
R106W neurons (One-tailed Wilcoxon Signed Rank). (d) Heatmap displaying log2 fold changes 659 
among protein-coding DEGs in excitatory and inhibitory neurons of Mecp2 mutant mice, 660 
compared across cell types. (e) Left graph, Distribution of constitutive, EXC- or INH-enriched 661 
genes among T158M and R106W protein-coding DEGs, compared against genomic distribution 662 
(Chi-square Goodness-of-Fit). Right graph, Bar plot summarizing R106W DEGs in excitatory 663 
neurons, partitioned by cell type-enriched or constitutive genes, and which are preferentially 664 
upregulated or downregulated. Red indicates statistical significance (One-tailed Fisher’s Exact 665 
Test). (f) Enrichment map of pre-ranked Gene Set Enrichment Analysis (GSEA) functional 666 
network associations. Data represents DEGs from R106W (top) and T158M (bottom) excitatory 667 
neurons (P-value < 0.01, Q-value < 0.1). Nodes denote functional categories, colored by 668 
Normalized Enrichment Score (NES). Line weight denotes extent of gene overlap between 669 
connected nodes. Red text highlights the similarity in functional annotations between both 670 
genotypes. (g) Boxplots comparing the log2 FPKM distribution of actively expressed genes 671 
against T158M, R106W, and shared DEGs for each cell type (Pairwise Wilcoxon Rank Sum P 672 
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displayed). *P < 0.5, **P < 0.01, ***P < 0.001, ****P < 0.0001, n.s. = not significant. See also 673 
Supplementary Figs. 5 and 6.674 
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 675 
Figure 4. Genome-wide length-dependent transcriptional changes in RTT mutant mice. (a) 676 
Genome-wide log2 fold changes in R106W mice (n = 2) compared to TAVI mice (n = 2) at 6 677 
weeks of age using GRO-seq. Top, Lines represent mean fold change in expression for genes 678 
binned according to gene length (200 gene bins, 40 gene step) as described in
27
. Ribbon 679 
represents SEM of genes in each bin. Bottom, Smoothed scatterplot depicting LOESS correlation 680 
between gene length and log2 fold change for all individual protein-coding genes detected in 681 
GROseq. Genes in red highlight R106W DEGs identified from sorted excitatory and inhibitory 682 
neuronal nuclei. (b,c) Same as in (a), but using total RNA-seq analysis of whole cell (b) or 683 
nuclear (c) RNA isolated from left or right cortex of the same mice at 6 weeks of age (n=2). (d) 684 
Top, Diagram of RNA distribution across subcellular compartments. Bottom, Area proportional 685 
Venn diagram comparing overlap in gene expression changes between nuclear RNA, whole cell 686 
RNA, and nascent RNA. (e) Cumulative distribution function of gene lengths for all upregulated 687 
and downregulated protein-coding genes among nascent, nuclear, and whole cell RNA pools (n = 688 
10,390 genes, Kolmogorov-Smirnov). (f) Top, Boxplots depicting median log2 fold changes in 689 
R106W mice between nascent, nuclear, and whole cell RNA pools, classified by the direction of 690 
gene misregulation (n = 10, 390 genes, Pairwise Wilcoxon Rank Sum P displayed). Gene groups 691 
are arranged by median gene length (black bar on top). Arrows highlight the percentage of 692 
10,390 genes that display similar (38.4% of expressed genes), opposite (48%), or dynamic 693 
changes (13.6%) across subcellular RNA pools. Bottom, Heatmap displaying statistical 694 
enrichment of T158M and R106W DEGs in excitatory neurons among gene groups (One-tailed 695 
Fisher’s Exact Test). (g) DAVID Gene ontology terms (Benjamini P < 0.01, FDR < 0.05) for 696 
Group A and Group G sets of genes defined in (f). (h) Top, Diagram of RT-PCR primer design 697 
to measure mature and primary RNA transcripts. Bottom, Data shows overall trend in gene 698 
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expression mean fold changes using primers against primary and mature RNA transcripts (left) 699 
or primary transcripts only (right)_across individual genes from Group A/C (n = 7 genes), Group 700 
B (n = 5 genes), and Group D (n = 5 genes) in R106W compared to TAVI mice (Two-way 701 
ANOVA). Data depicts mean ± S.D. (i) Mean log2 fold change in 6-week R106W (red; n = 4) 702 
and T158M (orange, n = 4) sorted excitatory (left) and inhibitory neurons (right) using genes that 703 
are also detected in GRO-seq. *P < 0.5, **P < 0.01, ***P < 0.001, ****P < 0.0001, n.s. = not 704 
significant. See also Supplementary Figs. 7-9.  705 
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 706 
Figure 5. T158M and R106W differentially expressed genes in mosaic female mice. (a) RTT-707 
like phenotypic score in TAVI (n = 12), T158M (n = 4), and R106W (n = 9) heterozygous 708 
female mice (Two-way ANOVA). Data depicts mean ± SEM. (b) FACS isolation of excitatory 709 
neuronal nuclei from the cortex of heterozygous TAVI, T158M, or R106W female mice. (c) 710 
Biotin signal intensity from FACS-isolated populations depicted in (b) (nT158M = 4, nR106W = 9, 711 
Two-way ANOVA). Data depicts mean ± SEM. (d) X-inactivation ratios among cortical 712 
excitatory neurons in all sorted female mice, displayed as a percentage of the FACS-sorted WT 713 
population (nTAVI = 12, nT158M = 4, nR106W = 9, One-way ANOVA). Data points in red indicate 714 
samples used for RNA-seq. Data depicts mean ± SEM. (e) Bar graph showing the cell and non-715 
cell autonomous distribution of total protein-coding DEGs identified from T158M and R106W 716 
female mice. (f) Principal component analysis of WT and MUT cell populations isolated from 717 
TAVI, T158M, and R106W female mice. (g) Heatmap displaying log2 fold changes among the 718 
total number of protein-coding DEGs detected in both WT and MUT populations from T158M 719 
or R106W female mice. Note genes that overlap across genotype (n = 194). (h) Proportion of cell 720 
autonomous (CA) and non-cell autonomous (NCA) genes that overlap between T158M and 721 
R106W female excitatory neurons (One-tailed Fisher’s Exact Test). (i) Boxplots comparing 722 
absolute log2 fold change between cell autonomous and non-cell autonomous shared DEGs (n = 723 
185) between T158M and R106W female mice (One-tailed Wilcoxon Signed Rank). (j) 724 
Enrichment map of pre-ranked GSEA functional network associations (P-value < 0.01, Q-value 725 
< 0.1). Data represents DEGs that overlap between T158M and R106W mice (n = 185). Nodes 726 
denote functional categories, colored by Normalized Enrichment Score (NES). Line weight 727 
denotes extent of gene overlap between connected nodes. *P < 0.5, **P < 0.01, ***P < 0.001, 728 
****P < 0.0001, n.s. = not significant. See also Supplementary Fig. 10. 729 
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Experiment Cell Type Genotype 




















Excitatory Neurons TAVI (Control) 13877 10926 2951 - - 24.9 [9.9 - 61.3] 46.5% 28.5% 24.9% 
Inhibitory Neurons TAVI (Control) 10369 8319 2050 - - 25.4 [10.3 - 61.5] 46.8% 24.3% 28.8% 
Cell Type-enriched 
Gene Expression 
Excitatory Neurons TAVI (Control) 4593 3958 635 - 0.75 [0.41 - 1.46] 50.6 [21.5 - 110.1] - 100% - 




T158M 197 177 20 63.8% DOWN 0.45 [0.33 - 0.62] 88.6 [33.5 - 173.1] 16.4% 49.2% 34.5% 
R106W 425 386 39 61.7% DOWN 0.44 [0.34 - 0.61] 82.5 [36.7 - 146.0] 17.6% 51.3% 31.1% 
Shared DEGs 75 69 6 65.2% DOWN see Figure 3D 109.8 [49.9 - 184.1] 14.5% 52.2% 33.3% 
Inhibitory Neurons 
T158M 146 143 3 62.9% UP 0.45 [0.29 - 0.55] 107.8 [41.4 - 188.7] 20.3% 44.8% 35.0% 
R106W 758 697 61 56.2% UP 0.41 [0.33 - 0.56] 40.5 [19.1 - 102.9] 29.4% 35.3% 35.3% 







T158MWT 42 28 14 64.3% DOWN 0.52 [0.49 - 0.79] 54.6 [27.2 - 112.6] - - - 
R106WWT 346 294 52 62.2% UP 0.64 [0.47 - 0.93] 51.4 [21.0 - 140.4] - - - 
T158MMUT 585 516 69 67.2% DOWN 0.49 [0.40 - 0.73] 51.2[20.4 - 113.2] - - - 
R106WMUT 634 569 65 52.2% UP 0.54 [0.43 - 0.83] 65 [31.7 - 142.1] - - - 
SharedMUT 207 185 22 65.9% DOWN see Figure 5I 77.5 [36.2 - 143.6] - - - 
 730 
Table 1 Summary of Differentially Expressed Genes (DEGs) identified in the study 731 
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Online Methods 732 
Generation of Mouse Lines The targeting construct used for homologous recombination at the 733 
Mecp2 locus in murine ES cells was cloned in two arms by PCR amplification of sv129 genomic 734 
DNA. The 5′ arm was PCR amplified with 5′-AGGAGGTAGGTGGCATCCTT-3′ and 5′735 
-CGTTTGATCACCATGACCTG-3′ primers, whereas the 3′ arm was PCR amplified with 5736 
′-GAAATGGCTTCCCAAAAAGG-3′ and 5′-AAAACGGCACCCAAAGTG-3′ primers. 737 
Restriction sites at the ends of each arm were created using nested primers for cloning into a 738 
vector containing a loxP-flanked neomycin cassette (Neo) and a diphtheria toxin A negative-739 
selection cassette. QuikChange (Stratagene) insertional mutagenesis was used to generate the 740 
Mecp2
Tavi
 targeting construct by inserting the Tavi tag immediately upstream of the Mecp2 stop 741 
codon within the 5’ arm. The portion of the Tavi tag containing the biotinylation consensus 742 
sequenced flanked by 5’ NaeI and 3’ BspHI restriction sites was inserted through two rounds of 743 
mutagenesis: 744 
 745 
Round 1 Forward: 5’-746 
GACCGAGAGAGTTAGCGCCGGCCTGAACGACATCTTCGAGTCATGACTTTACATAG747 
AGCG-3’ 748 





Round 2 Forward: 5’-753 
CTGAACGACATCTTCGAGGCTCAGAAAATCGAATGGCACGAATCATGACTTTACATA754 
GAG-3’ 755 




The portion of the tag containing the TEV protease cleavage site was inserted upstream of the 760 
NaeI restriction site with a third round of mutagenesis: 761 
 762 
Round 3 Forward: 5’-763 
GACCGAGAGAGTTAGCGAAAACCTGTATTTTCAGGGCGCCGGCCTGAACGACATC-3’ 764 





 targeting constructs bearing independent RTT-associated point 768 
mutations, QuikChange site-directed mutagenesis was used to mutate MeCP2 arginine 106 to 769 
tryptophan and MeCP2 threonine 158 to methionine within the 3’arm and 5’arm, respectively. A 770 
single nucleotide at codon T160 also underwent site-directed mutagenesis for a silent mutation to 771 
introduce a BstEII restriction site to correctly identify targeted ES cells. 772 
To generate conditional R26
cBirA
 transgenic mice, PCR primers containing AscI 773 
restriction sites and a Kozak consensus sequence were used to subclone the BirA coding 774 
sequence and insert it downstream of both a CAG promoter and a floxed transcriptional 775 
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After confirmation by Sanger sequencing and linearization with NotI (Mecp2
Tavi
 targeting 778 
construct and its mutant variants) or SgfI (cBirA targeting construct), the constructs were 779 
electroporated into sv129-derived murine ES cells. Correctly targeted ES cells were 780 
independently injected into C57BL/6 blastocysts and subsequently implanted into 781 
pseudopregnant females. Agouti offspring were screened by southern blot and PCR genotyping 782 









alleles. In the case of the Mecp2
Tavi
 allele and its mutant variants, the resulting offspring were 784 
mated with C57BL/6 EIIa-cre mice to ensure germline deletion of the floxed Neo cassette 785 
between Mecp2 exons 3 and 4. 786 
 787 
Additional Mouse lines Dlx5/6-Cre (Stock #008199) and EIIa-Cre (Stock #003724) mice were 788 
obtained from The Jackson Laboratory (Bar Harbor, ME)
31,36
. NeuroD6/NEX-Cre mice were 789 




Animal Husbandry Experiments were conducted in accordance with the ethical guidelines of 792 
the US National Institutes of Health and with the approval of the Institutional Animal Care and 793 
Use Committee of the University of Pennsylvania. All of the experiments described were 794 
performed using mice on a congenic sv129:C57BL/6J background with the knock-in/transgenic 795 
alleles backcrossed to C57BL/6J mice (The Jackson Laboratory) for at least five generations, 796 
unless otherwise stated. Mice were housed in a standard 12h light/12h dark cycle with access to 797 
ample amounts of food and water. Mice bearing the Tavi tag were genotyped using a bipartite 798 
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primer PCR-based strategy to detect the Tavi tag at the 3’-end of the endogenous Mecp2 gene 799 
(Forward: 5’-CACCCCGAAGCCACGAAACTC-3’, Reverse: 5’-800 
TAAGACTCAGCCTATGGTCGCC-3’) and give rise to a 318-bp product from the wild-type 801 
allele and a 388-bp product from the tagged allele. Mice bearing the BirA transgene were 802 
genotyped using a tripartite primer PCR-based strategy to detect the presence or absence of the 803 
CAG promoter at the Rosa26 locus (Forward:5’-TGCTGCCTCCTGGCTTCTGAG-3’, Reverse 804 
#1: 5’-GGCGTACTTGGCATATGATACAC-3’, Reverse #2: 5’-805 
CACCTGTTCAATTCCCCTGCAG-3’) and give rise to a 173-bp product from the wild-type 806 
allele and a 477-bp product from the transgene-bearing allele. Mice bearing Cre-recombinase 807 





Phenotypic Assessment For tagged Mecp2 knock-in mice, phenotypic scoring was performed 811 
on a weekly basis for the presence or absence of overt RTT-like symptoms as previously 812 
described
33
. Investigator was blinded to genotypes during phenotypic assessment of mice. For 813 
BirA transgenic mice, no formal scoring was performed. However, R26
BirA
 heterozygous and 814 
homozygous mice are viable, fertile, and devoid of any gross abnormalities, consistent with 815 
previously engineered transgenic mice that express BirA either ubiquitously or within restricted 816 




Immunofluorescence and Microscopy Mice were anesthetized with 1.25% Avertin (wt/vol), 819 
transcardially perfused with 4% paraformaldehyde (wt/vol) in 0.1M sodium-potassium 820 
phosphate buffered saline and postfixed overnight at 4°C. Brains were coronally or sagittally 821 
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sectioned at 20µm using a Leica CM3050 S cryostat. Immunofluorescence on free-floating 822 
sections was performed as previously described
18
, except sections were permeabilized with 0.5% 823 
Triton without methanol for 20 minutes, and sections were blocked overnight with 10% Normal 824 
Goat Serum and 1:100 unconjugated goat anti-mouse IgG (Sigma M5899). The following 825 
primary antibodies were incubated at 4°C overnight: rabbit anti-MeCP2 C-terminus (1:1000, in 826 
house), rabbit anti-nucleolin (1:1000, Abcam ab22758), mouse anti-parvalbumin (1:500, 827 
Millipore MAB1572), rabbit anti-calretinin (1:1000, Swant 7699/3H), mouse anti-GAD67 828 
(1:500, Millipore MAB5406), mouse anti-NeuN (1:500, Millipore MAB377). For rat anti-829 
somatostatin (1:250, Millipore MAB354MI), primary incubation was performed for 48 hours at 830 
4°C. Fluorescence detection of primary antibodies was performed using Alexa 488-conjugated 831 
goat anti-rabbit (1:1000, Invitrogen A11008), Alexa 488-conjugated goat anti-mouse (1:1000, 832 
Invitrogen A11029), or Alexa 488 goat anti-rat (1:1000, Invitrogen A11006). Fluorescence 833 
detection of biotin was performed simultaneously with Streptavidin Dylight 650 (1:1000, Fisher 834 
84547) for fluorescence microscopy and Streptavidin Dylight 550 (1:1000, Fisher 84542) for 835 
confocal microscopy. Sections were counterstained with DAPI (1:1000, Affymetrix 14564) to 836 
visualize DNA before mounting with Fluoromount G (SouthernBiotech). Images were acquired 837 
using a Leica DM5500B fluorescent microscope with a Leica DFC360 FX digital camera 838 
(region-specific biotinylation, quantification of neuronal cell type-specific markers) or a Leica 839 
TCS SP8 Multiphoton confocal microscope (representative images of neuronal cell type specific 840 
markers, subcellular localization of MeCP2). Images were acquired using identical settings for 841 
laser power, detector gain amplifier offset and pinhole diameter in each channel. Image 842 
processing was performed using ImageJ and Adobe Photoshop, including identical adjustments 843 
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of brightness, contrast, and levels in individual color channels and merged images across 844 
genotypes. 845 
 846 
Quantitative Western analysis Quantitative Western blot was performed using Odyssey 847 
Infrared Imaging System (Licor). Primary antibodies used in this study include rabbit anti-848 
MeCP2 C-terminus (1:4000, in house), mouse anti-MeCP2 N-terminus (1:4000, Sigma M7433), 849 
mouse anti-NeuN (1:500, Millipore MAB377), rabbit anti-Avi tag (1:5000, Abcam ab106159, 850 
listed as anti-Tavi in main text, detects the minimal peptide substrate of biotin ligase BirA 851 
regardless of biotinylation status), rabbit anti-HDAC3 (1:1000, Santa Cruz sc-11417), rabbit 852 
anti-TBLR1 (1:1000, Bethyl A300-408A), rabbit anti-Sin3A, (1:500, Thermo Scientific PA1-853 
870), rabbit anti-Histone H3 (1:1000, Abcam ab1791), and rabbit anti-TBP (1:1000, Cell 854 
Signaling #8515). Secondary antibodies include anti-rabbit IRDye 680LT (1:10,000, Licor), anti-855 
mouse IRDye 800CW (Licor), Streptavidin Dylight 650 (1:10,000, Fisher 84547) and 856 
Streptavidin Dylight 800 (1:10,000, Fisher 21851). Quantification of protein expression levels 857 
was carried out following Odyssey Infrared Imaging System protocols. Scans of full-length 858 
Western blot membranes are provided in Supplementary Figs. 11-13. 859 
 860 
Co-immunoprecipitation using nuclear extracts Tissues were mined on ice and homogenized 861 
in ice cold lysis buffer (10 mM HEPES pH 7.9, 1.5mM MgCl2, 10mM KCl, 0.5% NP-40, 0.2mM 862 
EDTA, protease inhibitors). Nuclei were pelleted, washed and resuspended in nuclear extract 863 
(NE) buffer (20mM HEPES pH 7.9, 1.5mM MgCl2, 500mM KCl, 0.2mM EDTA, 10% glycerol, 864 
protease inhibitors). Nuclei were incubated in NE buffer at 4°C for two hours with rotation. 865 
Samples were cleared by ultracentrifugation with a TLA 100.3 rotor (Beckman Optima TL) at 866 
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4°C for 30 minutes and the supernatant taken for nuclear extract. Protein concentration was 867 
quantified using a modified Bradford assay (Bio-Rad). 1mg of nuclear extract was adjusted to 868 
300µl total volume with NE buffer to perform IP in duplicate. Protein G Dynabeads or 869 
Streptavidin M-280 Dynabeads (Life Technologies) were washed three times in PBS with 0.1% 870 
Tween-20 and 0.1% BSA. Nuclear extracts were cleared for 30 minutes at 4°C with 25µl Protein 871 
G Dynabeads. For streptavidin pulldown, 50µl of Streptavidin M-280 Dynabeads were added to 872 
the nuclear extract and incubated at 4°C for two hours with rotation. To test if the Tavi tag was 873 
required for streptavidin pulldown, nuclear extracts were split and incubated with or without 874 
200U TEV protease (Invitrogen) in the absence of a reducing agent and without agitation at 4°C 875 
for ≥ 4 hours prior to IP. For antibody immunoprecipitations, 5µg of antibody was added to the 876 
nuclear extract and incubated overnight at 4°C with rotation. Protein G beads were blocked in 877 
wash buffer overnight at 4°C with rotation. Blocked beads were then incubated with antibody-878 
bound nuclear extract for two hours at 4°C with rotation. Beads were washed four times in PBS 879 
with 0.1% Tween-20 and split into two equal volumes. Each sample was resuspended in 25µl 880 
loading buffer with 50mM DTT and boiled for 10 minutes at 95°C prior to loading on a 4-12% 881 
Bis-Tris NuPage gel (Life Technologies). 882 
 883 
Chromatin immunoprecipitation Forebrain tissues from male mice at 20 weeks of age were 884 
homogenized in cross-linking buffer (1% formaldehyde (wt/vol), 10mM HEPES (pH 7.5), 885 
100mM NaCl, 1mM EDTA, 1mM EGTA) and cross-linked for 5 minutes at RT. After quenching 886 
with 125mM glycine, cross-linked tissue was washed with ice-cold PBS and dounced with 16 887 
strokes in lysis buffer (50mM HEPES (pH 7.5), 140mM NaCl, 1mM EDTA, 1mM EGTA, 10% 888 
glycerol (vol/vol), 0.5% NP-40 (vol/vol), and 0.25% Triton X-100 (vol/vol) with protease 889 
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inhibitors). Nuclei were pelleted, washed and resuspended in chromatin buffer (10mM Tris-HCl 890 
(pH 8.0), 1mM EDTA, and 0.5mM EGTA with protease inhibitors). Chromatin was sonicated 891 
using a Diagenode Bioruptor, and salt and detergent were added to adjust the chromatin buffer to 892 
0.5% Triton X-100, 150mM NaCl, 10mM EDTA, and 0.1% sodium deoxycholate (DOC, 893 
vol/vol), and precleared at 4°C with Protein A Dynabeads (Invitrogen). For 894 
immunoprecipitation, 3µg of purified rabbit anti-MeCP2 IgG (in house) or non-specific rabbit 895 
IgG control (Millipore NI01) was incubated with 45µg of chromatin for 4 hours, followed by an 896 
overnight incubation with pre-blocked Protein A Dynabeads, at 4°C with rotation. Bead-bound 897 
chromatin was washed with low salt buffer (50mM HEPES pH 7.5, 150mM NaCl, 1mM EDTA, 898 
1% Triton X-100, 0.1% DOC), high salt buffer (50mM HEPES pH 7.5, 500mM NaCl, 1mM 899 
EDTA, 1% Triton X-100, 0.1% DOC), LiCl buffer (50mM Tris-HCl pH 8.0, 150mM NaCl, 900 
1mM EDTA, 0.5% NP-40, 0.5% DOC) and TE buffer (10mM Tris-HCl pH 8.0, 1mM EDTA). 901 
Chromatin was eluted with elution buffer (50mM Tris-HCl pH 8.0, 10mM EDTA, and 1% SDS 902 
(wt/vol)), digested with proteinase K (0.5mg ml
-1
), and reversed crosslinked at 65°C overnight. 903 
After RNase A treatment, DNA fragments were extracted with phenol/chloroform and ethanol-904 
precipitated. 905 
 Quantitative real-time PCR (qPCR) analysis was carried out using SYBR green detection 906 
(Life Technologies) on an ABI Prism 7900HT Real-Time PCR System (Applied Biosystems). 907 
The percent input for each amplicon was determined by comparing the average threshold cycle 908 
of the immunoprecipitated DNA to a standard curve generated using serial dilutions of the input 909 
DNA and interpolating the “fraction of input” value for this sample. 910 
 911 
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Sub-nuclear Fractionation To prepare nucleoplasm-enriched proteins, cortices were dounce 912 
homogenized in 5 ml NE10 buffer (20 mM HEPES, pH 7.5, 10 mM KCl, 1 mM MgCl2, 0.1% 913 
Triton X-100, and 15 mM β-mercaptoethanol) 30 times using a loose pestle. The resulting nuclei 914 
were washed with NE10 buffer and rotated in NE300 buffer (20 mM HEPES, pH 7.5, 300 mM 915 
NaCl, 10 mM KCl, 1 mM MgCl2, 0.1% Triton X-100, and 15 mM β-mercaptoethanol) for 1 hour 916 
at 4°C. Samples were centrifuged at 500 g for 5 minutes, and the supernatant, which represents 917 
the nucleosolic fraction, was collected and saved. The insoluble pellet, consisting of the 918 
chromatin-bound fraction, was washed in NE150 buffer and incubated with 500 units of 919 
benzonase (Sigma-Aldrich) for 5 minutes at room temperature. The pellet was then resuspended 920 
in 50 μl NE150 buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 10 mM KCl, 1 mM MgCl2, 0.1% 921 
Triton X-100, and 15 mM β-mercaptoethanol) and rotated for 1 hour at 4°C. Samples were 922 
centrifuged at 16,000 g, and the supernatant was collected as the chromatin-bound fraction. 923 
 924 
FACS Isolation of Neuronal Nuclei for RT-PCR and RNA-seq Nuclei were isolated from 925 
fresh cortical tissue for FACS under ice-cold and nuclease-free conditions. Mouse cortices were 926 
rapidly resected on ice and subjected to dounce homogenization in homogenization buffer 927 
(0.32M sucrose, 5mM CaCl2, 3mM MgAc2, 10mM Tris-HCl pH 8.0, 0.1% Triton, 0.1mM 928 
EDTA, Roche Complete Protease Inhibitor without EDTA). Homogenates were layered onto a 929 
sucrose cushion (1.8M sucrose, 10mM Tris-HCl pH 8.0, 3mM MgAc2 Roche Complete Protease 930 
Inhibitor without EDTA) and centrifuged in a Beckman Coulter L7 Ultracentrifuge at 25,000 931 
rpm at 4°C for 2.5 hours using a Beckman Coulter SW28 swinging bucket rotor. Nuclei were 932 
resuspended & washed once in blocking buffer (1x PBS, 0.5% BSA (Sigma A4503), RNasin 933 
Plus RNase Inhibitor (Promega)) and pelleted using a tabletop centrifuge at 5000 RCF at 4°C for 934 
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10 minutes. Nuclei were resuspended in blocking buffer to a concentration of ~6x10
6
 nuclei/ml, 935 
blocked for 20 minutes at 4°C with rotation, then incubated with Streptavidin Dylight 650 936 
(1:1000, Fisher 84547) and Alexa 488-conjugated anti-NeuN antibody (1:1000, Millipore 937 
MAB377X) for 30 minutes at 4°C with rotation. After a 5-minute incubation with 1:1000 DAPI 938 
to enable singlet detection during FACS, labeled nuclei were washed for an additional 30 939 
minutes at 4°C with blocking buffer, pelleted and resuspended in blocking buffer with 1% BSA. 940 
A BD Biosciences Influx cell sorter at the University of Pennsylvania Flow Cytometry and Cell 941 
Sorting Facility was used to identify cell type-specific populations of nuclei, and 1.2 – 2.5 x10
5
 942 
singlet nuclei from specified populations were directly sorted into Qiagen Buffer RLT Plus for 943 
immediate lysis and stabilization of RNA transcripts. Total nuclear RNA was processed using 944 
the Qiagen AllPrep DNA/RNA mini kit according to manufacturer instructions, with exception 945 
to the on-column DNaseI treatment. RNA was eluted from RNeasy mini spin columns and 946 
treated with DNaseI (Qiagen 79254) for 25 minutes at room temperature, then precipitated with 947 
glycogen/NaOAc and stored in ethanol at -80°C. Ethanol precipitation of nuclear RNA was 948 
carried out to completion prior to initiating RT-PCR or RNA-seq library construction. 949 
For RNA-seq, total RNA was prepared from FACS-isolated cortical nuclei of male mice 950 
at 6 weeks (TAVI, T158M, R106W, 2-3 mice pooled per biological replicate, 4 independently-951 
sorted biological replicates total) and female mice at 18 weeks (TAVI, T158M, R106W, 1 single 952 
mouse per biological replicate, 2 independently-sorted biological replicates total). No method of 953 
randomization was used to determine how animals were allocated to experimental groups, which 954 
was determined by genotype with matching age and sex. The numbers of biological replicates 955 
used for differential gene expression analysis are in compliance with ENCODE consortium long 956 
RNA-seq recommendations (≥2 replicates). Furthermore, the total amount of RNA isolated from 957 
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120,000-250,000 sorted nuclei was used as input for library construction; hence differential gene 958 
expression comparisons between FACS-isolated Mecp2 control and mutant neurons are 959 
performed using RNA from equivalent numbers of neuronal nuclei. Total RNA was depleted of 960 
ribosomal RNAs, subjected to 5 minutes of heat fragmentation, and converted to strand-specific 961 
cDNA libraries using the TruSeq Total RNA library prep kit with RiboZero depletion (Illumina). 962 
Multiplexed libraries were submitted for 100 paired-end sequencing on the Illumina HiSeq 963 
2000/2500 platform at the University of Pennsylvania Next Generation Sequencing Core facility, 964 
yielding approximately 30-40M total reads per library. 90-95% of total reads were uniquely 965 
mapped to the mouse Ensembl GRCm38/mm10 mouse genomic assembly. 966 
 967 
Real-Time PCR (RT-PCR) For RT-PCR of FACS-isolated cortical nuclei, total RNA was 968 
prepared (as described in preceding section) from 120,000 sorted nuclei of TAVI or R106W 969 
male mice at 6 weeks of age (2-3 mice pooled per biological replicate, 3 independently-sorted 970 
biological replicates total). For remaining RT-PCR assays, total RNA was isolated from whole 971 
tissue or unsorted cortical nuclei of WT, TAVI, T158M, or R106W mice as specified in figure 972 
legends (1 mouse per biological replicate, 3 biological replicates total). Total RNA was 973 
converted to cDNA with random hexamers using the SuperScript III First-Strand Synthesis 974 
System (Invitrogen). RT-PCR was performed on a ABI Prism 7900HT Real-Time PCR System 975 
(Applied Biosystems). To validate cell type-specific cortical nuclei populations (Fig. 2d and 976 
Supplementary Fig. 3i-j), exon-spanning Taqman gene expression assays to detect mRNA 977 
transcripts for the following genes: CRE (Mr00635245_cn), Mecp2 (Mm01193537_g1), Rbfox3 978 
(Mm01248771_m1), Gfap (Mm01253033_m1), Aif1 (Mm00479862_g1), Mog 979 
(Mm00447824_m1), Slc17a7 (Mm00812886_m1), Tbr1 (Mm00493433_m1), Gad1 980 
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(Mm04207432_g1), Slc35a1 (Mm00494138_m1), Ht3ar (Mm00442874_m1), Pvalb 981 
(Mm00443100_m1), Sst (Mm00436671_m1), Pgk1 (Mm00435617_m1), Actb 982 
(Mm00607939_s1), ß2m (Mm00437762_m1). A geometric mean was calculated to normalize 983 
mRNA expression levels to multiple housekeeping genes (Actb, ß2m, and Pgk1), and cell type-984 
enrichment for each sorted population was determined relative to the total mixed population of 985 
DAPI+ nuclei. For RT-PCR validation of low expressing genes and subcellular gene expression 986 
changes (Fig. 4h and Supplementary Figure 8), primers against primary transcripts and mRNAs 987 
were used (listed in Supplementary Table 2), and geometric means were calculated to normalize 988 
mRNA expression levels to multiple housekeeping genes (Actb, ß2m, and Pgk1). 989 
  990 
GRO-seq Nuclei were isolated from fresh cortical tissue of TAVI or R106W male mice at 6 991 
weeks of age (2 mice pooled per biological replicate, 2 biological replicates total) under ice-cold 992 
and nuclease-free conditions as described in the preceding section. After ultracentrifugation, 993 
nuclei were resuspended & washed once in PBS (1x PBS, RNasin Plus RNase Inhibitor 994 
(Promega)) and pelleted using a tabletop centrifuge at 5000 RCF at 4°C for 10 minutes. Nuclei 995 
were resuspended in PBS, pipetted through a 0.22µm filter and counted using a hemocytometer. 996 




 nuclei/100µl in 997 
glycerol storage buffer (50mM Tris pH 8.3, 40% glycerol, 5mM MgCl2, 0.1 mM), and flash 998 
frozen in liquid N2 for storage until needed. 999 
For each nuclear run-on (NRO), 100µl of nuclei was mixed with 46.5µl NRO Reaction 1000 
Buffer (10mM Tris pH 8.0, 5mM MgCl2, 1 mM DTT, 300mM KCl), 3.5µl Nucleoside Mix 1001 
(50µM ATP, 50µM GTP, 2µM CTP, 50µM Br-UTP, 0.4U/µl RNasin), and 50µl 2% Sarkosyl  1002 
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Nuclear Run On Stop Solution (20mM Tris pH 7.4, 10mM EDTA, 2% SDS). The NRO reaction 1003 
was performed at 30°C for 5 minutes, then terminated by a 20 minute incubation with DNAse I 1004 
at 37°C, followed by a hour-long incubation with 225µl NRO Stop Buffer (20mM Tris, pH 7.4, 1005 
10mM EDTA, 2% SDS) and Proteinase K at 55°C. Phenol-extracted RNA was fragmented with 1006 
0.2N NaOH, and BrdU-RNA was isolated three consecutive times with BrdU-antibody beads, 1007 
treated with enzymatic tobacco acid pyrophosphatase (TAP) and T4 polynucleotide kinase 1008 
(PNK) to remove the cap and 3’-phosphate and to add a 5’-phosphate, as well as Illumina 1009 





RNA-seq Mapping, Read Counting, and Differential Expression Analysis The mouse mm10 1013 
genomic sequence (Mus_musculus.GRCm38.75.dna.primary_assembly.fa.gz) and gene 1014 
information (Mus_musculus.GRCm38.75.gtf.gz) were downloaded from Ensembl release 75. 1015 
The genome files used for mapping were built by STAR (version 2.3.0)
60
 using the parameters 1016 
‘STAR --runMode genomeGenerate --runThreadN 12  1017 
--genomeDir ./ --genomeFastaFiles Mus_musculus.GRCm38.75.dna.primary_assembly.fa.gz --1018 
sjdbGTFfile Mus_musculus.GRCm38.75.gtf --sjdbOverhang 100’. The FASTQ files were 1019 
mapped to the mouse Ensembl GRCm38/mm10 genome assembly by STAR (version 2.3.0) 1020 
using the parameters ‘--genomeDir ENSEMBL_75_mm10 --runThreadN 10 --1021 
outFilterMultimapNmax 1 --outFilterMismatchNmax 3’. Perl scripts generated in-house were 1022 
used to count the number of read pairs that mapped to genic regions (exon + intron) for each 1023 
gene. If one end of a read pair overlapped with the annotated genomic region of a given gene and 1024 
the other did not, the read pair was included in the final count for that gene. The total number of 1025 
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read pairs that overlapped within a given gene represented the final read count for that gene. All 1026 
intron and exon-mapped reads were used for differentially expressed gene comparisons, which 1027 
were performed by using the R packages “edgeR” (v3.10.0)
61
 and “DEseq2” (v1.8.0)
62
. Genes 1028 
exhibiting low expression due to a substantially low number of mapped reads and whose edgeR 1029 
CPM values satisfied the condition ‘rowSums(cpm(data_y)) < 2’ were filtered out from 1030 
differential gene expression analyses. Conversely, genes with ‘rowSums(cpm(data_y)) ≥ 2’ were 1031 
retained for differential gene expression analyses. A false discovery rate < 0.05 was set to 1032 
identify differentially expressed genes, and no fold change cutoff was applied. For each 1033 
comparison, the results of both edgeR and DESeq2 analyses were merged into a final non-1034 
redundant and FDR-controlled list of genes to avoid method-specific biases. The mean fold 1035 
change and the mean FDR generated from both methods were used for generating plots and 1036 
heatmaps. 1037 
 1038 
RNA Binding Protein (RBP) Data Pre-processing and Analysis To determine the enrichment 1039 
of neuronally expressed RNA-binding proteins on gene transcripts, raw HITS-CLIP reads 1040 
derived from the mouse brain were obtained from publically available datasets in the GEO 1041 
repository (listed below). The quality of raw reads were assessed with FastQC
63
 and 1042 
contaminants were removed using Trimgalore
64
 with parameters ‘-q 15 --length 20 --stringency 1043 
5’. Remaining reads were aligned to a mouse reference genome derived from the Ensembl v75 1044 
archived assembly using STAR (version 2.5)
60
 with parameters ‘--outFilterMultimapNmax 1 --1045 
outFilterScoreMinOverLread 0 --outFilterMatchNminOverLread 0.5 --alignEndsType Local’. 1046 
Replicates were merged and then subsampled to match the sample with the lowest library size. 1047 
Genome annotation from Ensembl v75 and in-house developed scripts facilitated the calculation 1048 
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of RNA binding protein coverage in gene models. Genes not included in Groups A-H (Figure 4f) 1049 
were filtered out. For k-means clustering of RBPs, raw read counts were first normalized using 1050 
the variance stabilizing transformation function in “DESeq2”
62
, and the R packages “factoextra”, 1051 
“cluster”, and “NbClust” were used to perform a Silhouette coefficient analysis and cluster genes 1052 
based on the optimal k number of clusters. The Kruskal-Wallis test, followed by a post-hoc 1053 
Wilcoxon Rank Sum Test with Holm’s correction for multiple comparisons, was used to identify 1054 
statistically significant differences in RNA-binding protein enrichment within each gene cluster. 1055 
RBP gene clusters were then used to perform One-tailed Fisher’s Exact Test with genes from 1056 
Groups A-H to identify RBP enrichments that significantly associate with genes displaying 1057 
subcellular differences in gene expression changes in R106W mutant mice. 1058 
HITS-CLIP datasets used for RBP Analysis 
AGO2 (Rep 1-6/9-12) GSE73058 PMID: 26602609
APC (Rep 1-4) SRP042131 PMID: 25036633 
MBNL1 (Rep 1-2) GSE39911 PMID: 22901804 
MBNL2 (Rep 1-3) GSE38497 PMID: 22884328 
ELAVL1 (Rep 1-2) GSE45148 PMID: 21784246 
FMR1 (Rep 1-2) GSE45148 PMID: 21784246 
FUS (Rep 1-3) GSE40651 PMID: 23023293 
TAF15 (Rep 1-2) GSE43294 PMID: 23416048 
TDP43 GSE40651 PMID: 23023293 
RBFOX1 SRP030031 PMID: 24213538 
RBFOX2 SRP030031 PMID: 24213538 
RBFOX3 (Rep 1-5) SRP039559 - 
 1059 
 1060 
Functional Enrichment of Differentially Expressed Genes For DAVID gene ontology, a list 1061 
of differentially expressed protein-coding genes was compared to a background list of actively 1062 
expressed protein-coding genes from their respective cell type. Statistically significant terms 1063 
(Benjamini P < 0.01, FDR < 0.05) were plotted for Figures S3C-D. For Gene Set Enrichment 1064 
Analysis (GSEA), we performed a seeded, pre-ranked GSEA from lists of differentially 1065 
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expressed protein-coding genes (ranked by fold change) using the September 2015 Mouse GO 1066 
Gene Set Release (http://download.baderlab.org/EM_Genesets/September_24_2015/Mouse/). 1067 
GSEA network associations (P-value < 0.1, Q-value < 0.1) were visualized using the Enrichment 1068 
Map application (v2.0.1) in Cytoscape (v3.2.1)
65,66
, and clustered using gene set overlap 1069 
coefficients. 1070 
 1071 
Principal Components Analysis (PCA) PCA analyses were performed with the top 500 genes 1072 
exhibiting the highest row variance using the “plotPCA” function in the R package “DESeq2”. 1073 
Principal components were plotted using Graphpad Prism version 6.0 for Mac (GraphPad 1074 
Software, La Jolla California USA, www.graphpad.com). 1075 
 1076 
Determination of Actively Expressed Genes Actively expressed genes for excitatory and 1077 
inhibitory neurons were determined by calculating the normalized FPKM (zFPKM) and using 1078 
ZFPKM ≥ 3 for the active gene cutoff as previously described67.  1079 
 1080 
Statistical Analyses Statistical analyses were performed using Graphpad Prism version 6.0 for 1081 
Mac (GraphPad Software, La Jolla California USA, www.graphpad.com) and R
68
. No statistical 1082 
method was used to estimate sample size, as pre-specified effect sizes were not assumed. No 1083 
animals or samples were excluded from analyses. Individual statistical tests are fully stated in the 1084 
main text or figure legends. Comparisons of normally distributed data consisting of two groups 1085 
with equal variances (F-test equality of variance P > 0.05) were analyzed using Student’s T-test, 1086 
and unequal variances (F-test equality of variance P < 0.05) using Students T-test with Welch’s 1087 
correction for unequal variance. Comparisons of normally distributed data consisting of three or 1088 
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more groups were analyzed using One-way ANOVA with the appropriate post-hoc test. 1089 
Comparison of two or more factors across multiple groups was analyzed using a Two-way 1090 
ANOVA with Sidak’s correction for multiple comparisons. Comparisons of non-normally 1091 
distributed data were analyzed using the Mann-Whitney/Wilcoxon test (two groups) or the 1092 
Kruskal-Wallis test (three or more groups) with the appropriate post-hoc test. For multiple 1093 
comparisons, all p-values are adjusted using the Holm-Bonferroni correction unless otherwise 1094 
indicated. Experimental design and analytical details are also listed in the Life Sciences 1095 
Reporting Summary. 1096 
 1097 
Main Figure Statistical Analyses 1098 
Figure 1 Utilization and characterization of Mecp2
Tavi
 mice and associated RTT variants 1099 
(e) nreplicates = 3, One-way ANOVA [F = 25.55, P = 0.0012]; Tukey’s multiple comparisons 1100 
correction applied. (f) Left, nWT = 4, nTAVI = 5, nT158M = 4, nR106W = 4; One-way ANOVA [F = 1101 
12.4, P = 0.0004]; Sidak’s multiple comparisons correction applied. Right, nWT = 4, nTAVI = 5, 1102 
nT158M = 4, nR106W = 4;One-way ANOVA [F = 0.2977, P = 0.8264]; Sidak’s multiple 1103 
comparisons correction applied. (g) nWT = 20, nTAVI = 11, nKO = 6, nT158M = 6, nR106W = 12; One-1104 
way ANOVA [F = 20.05, P < 0.0001]; Tukey’s multiple comparison correction applied. (j) nWT 1105 
= 31, nTAVI = 23, nKO = 17, nT158M = 39, nR106W = 26, Mantel-Cox [χ2 = 109.3, df = 4, P < 1106 
0.0001]. 1107 
 1108 
Figure 2 Cell type-specific transcriptional profiling of neuronal nuclei  1109 
(d) nreplicates = 3, Two-way ANOVA, Control [Cell Type-Gene Interaction, F = 42.68, P < 0.0001; 1110 
Cell Type, F = 222.0, P < 0.0001; Gene, F =80.03, P < 0.0001], Non-Neuronal [Cell Type-Gene 1111 
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Interaction, F = 12.47, P < 0.0001; Cell Type, F = 109.8, P < 0.0001; Gene, F = 7.655, P = 1112 
0.0027], EXC-specific [Cell Type-Gene Interaction, F = 4.376, P = 0.0198; Cell Type, F = 1227, 1113 
P < 0.0001; Gene, F = 0.3267, P = 0.5756], INH-specific [Cell Type-Gene Interaction, F = 1114 
3.047, P = 0.0040; Cell Type, F = 646.5, P < 0.001; Gene, F = 2.916, P = 0.033]; Dunnett’s 1115 
multiple comparisons correction applied. 1116 
 1117 
Figure 3 T158M and R106W differentially expressed genes at 6 weeks of age 1118 
(c) One-tailed Wilcoxon Signed Rank, Excitatory PUpregulated = 4.357e-3, Excitatory PDownregulated 1119 
= 7.345e-3, Inhibitory PUpregulated = 4.575e-09, Inhibitory PDownregulated = 1.684e-05. (e) Chi-square 1120 
Goodness-of-Fit, Excitatory PT158M < 2.2e-16 [χ2 = 182.2, df = 2], Excitatory PR106W < 2.2e-16 1121 
[χ2 = 401.11, df = 2], Inhibitory PT158M < 2.2e-16 [χ2 = 119.94, df = 2], Inhibitory PR106W < 2.2e-1122 
16 [χ2 = 346.86, df = 2]. (f) Two-tailed Kruskal-Wallis Rank Sum, Excitatory P  < 2.2e-16 [χ2 = 1123 
418.2, df = 3], Inhibitory P  < 2.2e-16 [χ2 = 1026.9, df = 3]; Pairwise Wilcoxon Rank Sum P 1124 
displayed. 1125 
 1126 
Figure 4 Genome-wide length-dependent transcriptional changes in RTT mutant mice 1127 
(e) Top, n = 10,390 genes, Kolmogorov-Smirnov P < 2.2e-16 for each nascent or nuclear RNA 1128 
versus whole cell RNA comparison, no correction for multiple comparisons. (f) n = 10, 390 1129 
genes, Kruskal-Wallis PGroup A < 2.2e-16 [χ2 = 2664.8, df = 2], PGroup B < 2.2e-16 [χ2 = 290.18, df 1130 
= 2], PGroup C < 2.2e-16 [χ2 = 2403.3, df = 2], PGroup D < 2.2e-16 [χ2 = 319.36, df = 2], PGroup E < 1131 
2.2e-16 [χ2 = 1483.8, df = 2], PGroup F < 2.2e-16 [χ2 = 1385.8, df = 2], PGroup G < 2.2e-16 [χ2 = 1132 
2522.9, df = 2], PGroup H < 2.2e-16 [χ2 = 2442.7, df = 2]; Pairwise Wilcoxon Rank Sum P 1133 
displayed. (h) Left, Primary Transcripts + mRNA RT-PCR (Group Trend), nGroup A/C = 7 genes, 1134 
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nGroup B = 5 genes, nGroup D = 5 genes, Two-way ANOVA, [Subcellular Compartment-Gene Group 1135 
Interaction, F = 5.699, P = 0.0084; Subcellular Compartment, F = 1.419, P = 0.2436; Gene 1136 
Group, F = 16.14, P < 0.0001]; Sidak’s multiple comparisons correction applied. Right, Primary 1137 
Transcripts only RT-PCR (Group Trend), nGroup A/c = 7 genes, nGroup B = 5 genes, nGroup D = 5 1138 
genes, Two-way ANOVA, [Subcellular Compartment-Gene Group Interaction, F = 0.182, P = 1139 
0.8345; Subcellular Compartment, F = 0.1334, P = 0.7176; Gene Group, F = 15.12, P <0.0001]; 1140 
Sidak’s multiple comparisons correction applied. 1141 
 1142 
Figure 5 T158M and R106W differentially expressed genes in mosaic female mice 1143 
(a) Two-way ANOVA [Genotype-Time Interaction, F = 2.987, P = 0.0712; Genotype, F = 41.14, 1144 
P < 0.0001; Time, F = 7.332, P = 0.0129; Subjects (matching), F = 1.873, P = 0.0744]. (b) 1145 
FACS isolation of cortical mosaic excitatory neuronal nuclei from heterozygous TAVI, T158M, 1146 
or R106W female mice. (c) nT158M = 4, nR106W = 9, Two-way ANOVA [Population-Genotype 1147 
Interaction, F = 0.3320, P = 0.5703; Population, F = 111.1, P < 0.0001; Genotype, F = 0.332, P = 1148 
0.5703]. (d) nTAVI = 12, nT158M = 4, nR106W = 9, One-way ANOVA [F = 0.9376, P = 0.4067]. (h) 1149 
One-tailed Fisher’s Exact Test [Odds Ratio = 19.3, P = 2.43e-05]. (i) One-tailed Wilcoxon 1150 




Methods-Only References 1154 56. Xiao, C. et al. MiR-150 Controls B Cell Differentiation by Targeting the Transcription 1155 Factor c-Myb. Cell 131, 146–159 (2007). 1156 57. Boer, E. de et al. Efficient biotinylation and single-step purification of tagged 1157 transcription factors in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 1158 
100, 7480–5 (2003). 1159 58. Driegen, S. et al. A generic tool for biotinylation of tagged proteins in transgenic mice. 1160 
Transgenic Res 14, 477–82 (2005). 1161 59. Greer, C. B. et al. Histone Deacetylases Positively Regulate Transcription through the 1162 Elongation Machinery. Cell Rep. 13, 1444–1455 (2015). 1163 60. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics bts635 (2012). 1164 doi:10.1093/bioinformatics/bts635 1165 61. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for 1166 differential expression analysis of digital gene expression data. Bioinforma. Oxf. Engl. 1167 
26, 139–140 (2010). 1168 62. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion 1169 for RNA-seq data with DESeq2. Genome Biol. 15, (2014). 1170 63. Andrews, S. Babraham Bioinformatics - FastQC A Quality Control tool for High 1171 Throughput Sequence Data. Available at: 1172 https://www.bioinformatics.babraham.ac.uk/projects/fastqc/. (Accessed: 28th April 1173 2017) 1174 
 57



















TAVIMecp2 allele: T158M R106W




TEV Protease: - + - + - + - +





































g h i j





















and DAPI for singlet
detection
4. FACS isolation
























































Gene Ontology category associated with downregulated genes
Gene Ontology category associated with upregulated genes


































































































































Gene Ontology category associated with
downregulated genes
Gene Ontology category associated with
upregulated genes
Cell
Autonomous
Non-Cell
Autonomous
Total
Overlap
* n.s. ****
B
io
ti
n
NeuN
Mecp2Tavi/+ Mecp2Tavi/T158M-Tavi Mecp2Tavi/R106W-Tavi
TAVI
WT 
nuclei
NEX-Cre T158M
WT 
nuclei
T158M
MUT 
nuclei
R106W
WT 
nuclei
R106W
MUT 
nuclei
n.s.
a b
h
f
j
i
g
c d e
